Influence of the Design of the Transmucosal Abutment on the Periimplant Bone Level
Influence of the Design of the Transmucosal Abutment on the Marginal Periimplant Bone Loss. Randomized Clinical Trial
Sponsor: Mozo Grau Ticare Implants
This NA trial investigates Peri-implant Bone Level and Peri-implant Bone Loss and is currently ongoing. Mozo Grau Ticare Implants leads this study, which shows 7 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Dec 2024 — Sep 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2021 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mozo Grau Ticare Implants
- University of Santiago de Compostela
For direct contact, visit the study record on ClinicalTrials.gov .